The Potential of Fetal MRI: Delivering Value Now and in the Future

UCSF pediatric radiology specialists address fetal MRI safety concerns and explain when to consider advanced imaging.

Hard Facts to Inform Hard Decisions: Treating the Fetal Heart

Anita J. Moon-Grady, MD, FAAP, director of the UCSF Fetal Cardiovascular Program, examines the reality of whether long-term outcomes are better for babies who had in utero interventions for certain heart defects, as well as the short-term ...

Genetic Diseases Linked to Nonimmune Hydrops: Distinctions in Diagnosis and Prognosis

In this short video, Maternal-Fetal Medicine and Genetics specialist, Dr. Teresa Sparks, MD, MAS, presents a recently published UCSF study of non-immune hydrops fetalis (NIHF) cases.

Fetal Neurology: New Frontiers

Ventriculomegaly and corpus callosum abnormalities are relatively common fetal ultrasound findings involving the brain. Neuroimaging specialists at the UCSF Fetal Treatment Center illustrate their consult process, showing the prognostic ...

Placenta Accreta Spectrum Disorder: Proven Strategies from a Multidisciplinary Team

Placenta accreta spectrum disorder is a varied and increasingly common complication of pregnancy, so ob/gyns need a firm grasp of risk factors and ultrasound signs

Tippi and Elianna’s Story: Stopping a Fatal Blood Disease Before Birth: Part 1

Tippi MacKenzie, MD, is stopping disease before it starts – in the womb. In 2017, she launched the world's first clinical trial of an in-utero stem cell transplant therapy. Her first patient, baby Elianna, was born just four months later.

Tippi, Elliott and Elianna’s Story: Little Girl Thrives After Fetal Stem Cell Transplant: Part 2

Working with a team of more than 100 UCSF specialists, Tippi MacKenzie, MD, and Elliott Vichinsky, MD, are leading work to bring cutting edge therapies to patients with genetic blood disorders.

Congenital Diaphragmatic Hernia: A Little Hole With Big Consequences

Specialists with the UCSF Fetal Treatment Center share the latest on prenatal techniques for detecting, evaluating and treating diaphragmatic hernias to optimize lung development and prevent deadly pulmonary hypertension. They also present ...

Exome Sequencing

Perinatologist and medical geneticist Mary Norton, discusses a genetic test called exome sequencing. With recent discoveries I'm genetics we can now test for many more genetic conditions.

Genetic Testing Update: When Is Exome Sequencing Valuable in Prenatal Diagnosis?

In this webinar, maternal-fetal medicine and genetics specialists, Drs. Mary Norton and Teresa Sparks discuss advances in genetic testing.

Prenatal Diagnosis of Congenital Heart Disease: Can We Make a Difference?

Anita Moon-Grady, MD, FAAP, FACC, discusses congenital heart disease (CHD), the most common cause of infant death due to birth defect in the United States.

Monochorionic Twins

Monochorionic twins are identical twins who share a single placenta between them. Two of the more significant complications that arise in these pregnancies are discussed by perinatologist and twin expert, Dr. Larry Rand.

The Difference Between Dichorionic and Monochorionic Twins

The number of placentas that a twin pregnancy has is critical in determining the best way to safely care for the pregnancy. Perinatologist and twin expert, Dr. Larry Rand, discusses the importance of early diagnosis and frequent monitoring.

Unequal Placental Sharing

Monochorionic twins have to share a single placenta but don’t always share it equally. Perinatologist and twin expert, Dr. Larry Rand, describes the clinical markers of this condition and when frequent ultrasound surveillance is important.

Twin to Twin Transfusion Syndrome: Part 1 of 2

Perinatologist and twin expert, Dr. Larry Rand, explains the clinical characteristics of TTTS, how it is diagnosed, the various stages of the condition and why it is so important to differentiate between those stages.

Twin to Twin Transfusion Syndrome: Part 2 of 2

Perinatologist and twin expert, Dr. Larry Rand, describes the risks and advantages of placental laser ablation therapy, the best treatment for TTTS that has reached stage 2 and beyond, as well as the expected long-term outcomes.